[{"NetIncomeLoss_1_Q1_USD":-21220000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":51174978.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":5774000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q1_USD":180000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q1_pure":0.825,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-47000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q1_pure":0.01,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-173391000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":66982.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q1_USD":0.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5885000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":388000.0,"OperatingLeaseExpense_1_Q1_USD":400000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":172145000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1_Q1_shares":66982.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":4863399.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":487000.0,"DueToRelatedPartiesCurrent_0_Q1_USD":1874000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":379000.0,"CommonStockSharesIssued_0_Q1_shares":51338801.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":171934000.0,"Assets_0_Q1_USD":382351000.0,"ShareBasedCompensation_1_Q1_USD":1865000.0,"AssetsCurrent_0_Q1_USD":324714000.0,"DepreciationAndAmortization_1_Q1_USD":300000.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ResearchAndDevelopmentExpense_1_Q1_USD":17258000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":1401000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-281000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":1142000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":1923000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":54000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q1_USD":49754000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":347000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":1862000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":487000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q1_USD":0.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-21220000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q1_USD":-47000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-21267000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":2185000.0,"OtherAssetsNoncurrent_0_Q1_USD":990000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":198939000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":295000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":546714000.0,"Liabilities_0_Q1_USD":55414000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-47000.0,"OperatingLeaseLiability_0_Q1_USD":1128000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1028000.0,"ShortTermInvestments_0_Q1_USD":122180000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":17.7,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"RestrictedCashNoncurrent_0_Q1_USD":871000.0,"CapitalLeasesIncomeStatementAmortizationExpense_1_Q1_USD":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":4444000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1865000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-13205000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":122180000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":487000.0,"LiabilitiesCurrent_0_Q1_USD":55016000.0,"AccountsPayableCurrent_0_Q1_USD":31864000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":199810000.0,"CommonStockSharesOutstanding_0_Q1_shares":51338801.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3595000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":487000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":671000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.065,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":441000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q1_pure":0.005,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":267208.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q1_USD":0.0,"OperatingLeasePayments_1_Q1_USD":223000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":1537000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":4994000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q1_pure":0.81,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-186390000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-219784000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-151000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":273000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":398000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":557000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"OperatingIncomeLoss_1_Q1_USD":-23143000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":6400000.0,"InvestmentIncomeInterest_1_Q1_USD":61000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"PreferredStockValue_0_Q1_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":1.82,"LiabilitiesAndStockholdersEquity_0_Q1_USD":382351000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1007000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":9438000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":833000.0,"OperatingExpenses_1_Q1_USD":23143000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":1028000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.41,"ProfitLoss_1_Q1_USD":-21220000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":103000.0,"StockholdersEquity_0_Q1_USD":326937000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1246000.0,"AssetsNoncurrent_0_Q1_USD":57637000.0,"LongTermInvestments_0_Q1_USD":49754000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"AccruedProfessionalFeesCurrent_0_Q1_USD":925000.0,"Ticker":"PCVX","CIK":"1649094","name":"VAXCYTE, INC.","OfficialName":"Vaxcyte Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1309224961.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210511"}]